Mexico’s Institute for Social Security (IMSS) has filed a complaint with the country’s competition regulator, COFECE, over what they believe to be a possible case of collusion between potential suppliers. The violation involves a current contest being held by the Institute for supply contracts in Integrated Laboratory Diagnostics services. The institute has said the complaint aims for COFECE “to employ its capabilities to safeguard the economic competition process and to determine whether possible absolute monopolistic practices have taken place to the detriment of the IMSS.”
The IMSS’s complaint details that, on December 12 2015 the Institute held a contest for 100% of its laboratory testing and diagnostics services through an Integrated Services scheme for a length of three years. Six service packages were up for grabs, each assigned to eight different regions.
As well as presenting a formal complaint, the Institute’s Internal Affairs section has also been notified in order to investigate the situation and determine where responsibility for the agreement lies. Despite the ongoing investigation and regardless of its outcome, all of the IMSS’ lab and diagnostics services are fully guaranteed.
Full content: Reporte México
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Subscribers Defend $4.7 Billion Antitrust Verdict Against NFL in Court Filings
Jul 19, 2024 by
CPI
Von der Leyen Calls for Competition Policy to Boost EU Companies’ Growth
Jul 19, 2024 by
CPI
Vermont AG Sues Pharmacy Benefit Managers Over Drug Prices
Jul 18, 2024 by
CPI
Australians Face Increased Stamp Prices Following ACCC Approval
Jul 18, 2024 by
CPI
Live Nation Seeks Dismissal of DOJ Antitrust Allegations
Jul 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI